Allena Pharmaceuticals, Inc. (ALNA): Price and Financial Metrics
ALNA Price/Volume Stats
| Current price | $0.08 | 52-week high | $1.17 |
| Prev. close | $0.07 | 52-week low | $0.06 |
| Day low | $0.06 | Volume | 276,971,600 |
| Day high | $0.15 | Avg. volume | 15,688,501 |
| 50-day MA | $0.14 | Dividend yield | N/A |
| 200-day MA | $0.30 | Market Cap | 9.16M |
ALNA Stock Price Chart Interactive Chart >
Allena Pharmaceuticals, Inc. (ALNA) Company Bio
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company’s lead product candidate includes ALLN-177, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It is also involved in developing ALLN-346 for patients with hyperuricemia and moderate to severe chronic kidney diseases. The company was founded in 2011 and is based in Newton, Massachusetts.
ALNA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -89.25% |
| 5-year | -96.30% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -53.71% |
| 2020 | -53.11% |
| 2019 | -49.91% |
Loading social stream, please wait...